Protecting Donors and Safeguarding Altruism in the United States. The Living Donor Protection Act
Alexander C. Wiseman
Clin J Am Soc Nephrol 13: 790–792, 2018. doi: https://doi.org/10.2215/CJN.13681217
The present state of transplantation in theUnited States can be most easily summarized as “good news/bad news.” On the positive side, improvements in shortterm outcomes have translated into measurable improvement in long-term survival (1), new allocation schema have increased opportunities for disadvantaged populations (2), and the absolute number of transplants performed annually continues to increase (3), in part due to strategies that facilitate living donation. The bad news, of course, is that these improvements are dwarfed by the growth of those waiting in need of a transplant (4). Although efforts to increase deceased organ donation are important, it would take fundamental changes in deceased donor management or clinical practice to more substantially affect the “need gap” via deceased donation. Efforts to facilitate living donation, specifically by reducing any barriers to living donation, are much more likely to affect transplant rates, thereby increasing the opportunity for patients with ESKD to receive the most optimal and cost-effective therapy. To this end, the American Society of Transplantation helped draft and drive introduction of the Living Donor Protection Act (LDPA).
The report can be downloaded here.